Epinephrine May Do More Harm Than Good For Cardiac Arrest

December 5, 2014

Provided by Rachel Cagan, American College of Cardiology

Study questions current international guidelines for resuscitation

For patients in cardiac arrest, administering epinephrine helps to restart the heart but may increase the overall likelihood of death or debilitating brain damage, according to a study published today in the Journal of the American College of Cardiology.

The study offers new data in an ongoing debate over the risks and benefits of using epinephrine to treat cardiac arrest, an often-fatal condition in which the heart stops beating. Epinephrine, also known as adrenaline, is a hormone that stimulates the heart and promotes the flow of blood. Current international guidelines recommend administering 1 milligram of epinephrine every 3-5 minutes during resuscitation.

The role of epinephrine is more and more questionable in cardiac arrest, said the studys lead author Florence Dumas, M.D., Ph.D., of the Parisian Cardiovascular Research Center in France. We need to constantly assess our procedures and protocols to make sure that the use of epinephrine is effective and done at the correct time.

She added that this study underscores the need for caution when using epinephrine. Administering epinephrine to patients in cardiac arrest has been shown to improve the chance of restarting the heart, known as return of spontaneous circulation or ROSC. But the new study adds to mounting evidence suggesting the drug harms patients chances of surviving past the post-resuscitation period with brain function intact.

Dumas and colleagues analyzed hospital records for more than 1,500 people admitted to a large Parisian hospital over a 12-year period. Patients included in the analysis had suffered out-of-hospital cardiac arrest, been resuscitated and achieved ROSC. Nearly three-quarters of the patients had received at least one dose of epinephrine.

The primary outcome measured was discharge from the hospital with normal or only moderately compromised brain functioning. Sixty-three percent of patients who did not receive epinephrine achieved this outcome, compared to only 19 percent of those who received epinephrine.

Patients receiving higher doses of epinephrine fared worse than those with lower doses. As compared to patients who received no epinephrine, those receiving 1-milligram doses were 52 percent more likely to have a bad outcome and those receiving 5-milligram or larger doses were 77 percent more likely to have a bad outcome.

See the article here:
Epinephrine May Do More Harm Than Good For Cardiac Arrest